In this episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, sits down with Kees van Ooik, Vice President of Clinical Technologies at Almac Clinical Technologies, to talk about the burden clinical trial sites face when one study runs on up to 15 applications. They discuss why single sign-on and data standards have been slow to take hold, and how established providers can modernize their systems without putting live studies at risk. The conversation also covers the difference between making a process electronic and truly digitizing it, and why eCOA calls for more than an add-on to an existing eClinical offering.
In this episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, sits down with Alice Biggane, Outcomes Innovation and Research...
In this episode of TransPerfect LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, sits down with Dr Michelle Longmire, CEO of...
In this episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, sits down with Stacie Hudgens, Chief Scientific and Strategy...
